The Society of Thoracic Surgeons (STS) today announced the launch of its latest surgical risk calculator designed for patients undergoing ascending aorta and aortic root surgery, with or without ...

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...

Hend Almesafri, 11, met John Catoliato, 2, and Teddy Carter, 3, for the first time in February just months after their ...

To address this question in detail, one must first have an accurate map of the diverse patterns of investment by SMC ...

New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure used to replace damaged heart valves, ...

Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe ...

Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.

A trend toward higher mortality in women with PPM who received a self-expanding valves deserves more scrutiny, though.